`l_UCENTIS'
`RAN l S ! ZL.JMAS
`Business Use Only
`
`Lucentis PFS (RFB002)
`
`TRD SubTeam meeting
`
`Meeting Date: May 31 and June 11 , 2012
`Meeting Notes Date: June 24, 2012
`Author:
`Room: WSJ-340.3 09
`
`Dial-in information: D
`
`T eleoorterences. m;g
`
`Team Members: (✓ = Present, * = part-time)
`
`Team Members : (✓ = Present,*= part-time)
`
`Executive Summary
`
`•
`•
`
`I
`I
`I
`
`I
`I
`I
`
`Lucentis CMC Subteam Meeting Minutes . Meeting Date : May 31 and June 11, 2012
`
`1 of 6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2078.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Minutes
`
`Pre-read
`
`I
`I
`I
`
`I
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : May 31 and June 1 1, 2012
`
`2 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2078 .002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`I
`I
`I
`
`I
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : May 31 and June 11, 2012
`
`3 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2078.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`I
`I
`I
`
`I
`
`□ -.
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : May 31 and June 11, 2012
`
`4 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2078.004
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`I
`
`I -I
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : May 31 and June 11, 2012
`
`5 of 6
`
`CONTAINS CONFIDENTIAL BUSI NESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2078.005
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Action Plan
`
`-
`
`Lucentis CMC Subteam Meeting Minutes. Meeting Date : May 31 and June 11, 2012
`
`6 of 6
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`Novartis Exhibit 2078.006
`Regeneron v. Novartis, IPR2021-00816
`
`